Hiroki Morizono Selected Research

Hiroki Morizono Research Topics

8	Hyperammonemia 03/2016 - 02/2002
6	Ornithine Carbamoyltransferase Deficiency Disease 01/2020 - 02/2002
3	Inborn Urea Cycle Disorders 01/2020 - 08/2007
1	COVID-19 01/2022
1	Critical Illness (Critically Ill) 01/2020
1	Type 2L Limb-Girdle Muscular Dystrophy 01/2019
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2019
1	Muscular Dystrophies (Muscular Dystrophy) 01/2019
1	Coma (Comas) 01/2017
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 01/2017
1	Cognitive Dysfunction 01/2017
1	Infections 09/2011
1	Leukoencephalopathies 02/2008
1	Vanishing White Matter Leukodystrophy with Ovarian Failure 02/2008
1	Diseases Newborn Infant 04/2003

7	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 01/2020 - 02/2002
6	N-acetyl glutamate synthetase deficiencyIBA 06/2012 - 12/2002
4	Urea (Carbamide)FDA LinkGeneric 01/2017 - 12/2005
3	EnzymesIBA 03/2016 - 01/2010
3	Amino-Acid N-Acetyltransferase (N-Acetylglutamate Synthase)IBA 06/2012 - 04/2003
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2016
2	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 04/2003
1	Oxygen (Dioxygen)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	AnoctaminsIBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	AmmoniaIBA 01/2017
1	Biocompatible Materials (Biomaterials)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 03/2016
1	Lysine (L-Lysine)FDA Link 06/2012
1	OrnithineIBA 06/2012
1	Glutamic Acid (Glutamate)FDA Link 06/2012
1	Glutamine (L-Glutamine)FDA Link 06/2012
1	CitrullineIBA 06/2012
1	Arginine (L-Arginine)FDA Link 06/2012
1	Proline (L-Proline)FDA Link 06/2012
1	Neutralizing AntibodiesIBA 09/2011
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 02/2008
1	ornithine transporter (ornithine translocase)IBA 12/2005